Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Explore the Innovation Trends Shaping Tomorrow’s Investment Landscape (click to learn more)
Sekur Private Data Advances Defense-Grade Secure Communications Platform (click to learn more)
Sorrento Resources Ltd. Intersects 33m of 2.12% TREO, Bottom Brook, Newfoundland (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
Pronorvista
X
Post by
Pronorvista
on Jan 29, 2024 7:42pm
ATE ( reading on ceo.ca
Canaccord will get involved in the secondary market, it is they who hold the majority of the warrants and participated in the financing at $6.00 Canaccord holds an important position to its
...more
(12)
•••
Jefnan1
X
Comment by
Jefnan1
on Jan 29, 2024 5:57pm
RE:RE:ATE
You must be dreaming. You talk about institutions in your comments. I can assure you a total of 40k shares traded in a day is not institutions. They would have no interest in a small Canadian company
...more
Innovation Moving Fast. Opportunity Windows May Move Faster.
posted May 14, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
The Innovation Report highlights transformative technologies and sectors attracting global investor attention. Learn how innovation is influencing future markets and why strategic positioning matters more than ever. ...Discover Trends
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 29, 2024 1:52pm
Just sold a whole wack
of shares not all filled, let us see if they bring the price back up to $1.00 lol
(1540)
•••
Duster340
X
Comment by
Duster340
on Jan 29, 2024 1:43pm
RE:ATE
i think more warrants being exercised right now, who drove the price back up "warrant holders" aka financial institutions. i am thinking about selling some more here in hopes that the sp
...more
(1)
•••
Pronorvista
X
Post by
Pronorvista
on Jan 29, 2024 1:23pm
ATE
Before $1.20 or $1.30 not much chance that the warrant will be exercised
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 29, 2024 1:15pm
Right at the exercise price
of $1.00 again strange, is the stock being manipulated to this level? some funny business lol
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 29, 2024 12:07pm
OK moving higher now
i think some shenanigans this morning with the wide spread, this morning was 93 on the bid and 97 on the ask.
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 29, 2024 10:31am
Maybe just greedy brookers?
a wider spread equals even less liquidity. When a stock has a low trading volume, it is considered illiquid because it is not easily converted to cash. As a result, a broker will require more
...more
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 29, 2024 10:03am
wide bid/ask spread. this is new for antibe?
makes it harder to trade "i hate it" What Determines a Stock's Bid-Ask Spread? By BARCLAY PALMER
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Jan 28, 2024 8:58am
RE:RE:RE:RE:also 🚩
Benedictus - from AGM, we know there is confidence on a few fronts. We also know there are discussions underway. No details, just that the company is doing what they can in advance. and
...more
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 26, 2024 12:12pm
More updates
coming soon with the financials in about 2 weeks time, i think march will be the next of "several" in the series of " a conversation with antibe" when they will announce that P2 is
...more
(11)
•••
Benedictus
X
Comment by
Benedictus
on Jan 25, 2024 10:53pm
RE:RE:RE:also 🚩
While the Jan 18 update was timely and informative, if mgt was relying on this alone to strengthen the sp and allow the discounted warrant exercise funds to flow in, they appear to have seriously
...more
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 25, 2024 12:56pm
Technical analysis
was just looking at the 3 year chart. looks really good if all goes well, has anyone ever heard of the saying "the bigger the base the bigger the case" that describes this stock
...more
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 22, 2024 8:51am
Q3 mid febuary
i will be interested to see how many warrants were exercised lol. and yes there will be a cash raise coming soon, i expect before the P2 results, just in case of failure. if they are not cashed up and
...more
(8)
•••
Montana5
X
Comment by
Montana5
on Jan 21, 2024 7:53pm
RE:RE:RE:also 🚩
A successful P2 for acute will likely move the share price to at least $2.50 for ATE to consider another equity issue. It would help self fund P3 and other potential developments (clinically and
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Podcasts